Updated:
Boston Scientific Ventures
Boston Scientific develops manufactures and markets medical devices worldwide. The firm formed in 1979 and its products reduce risk trauma cost procedure time...
Boston Scientific Ventures
Boston Scientific develops manufactures and markets medical devices worldwide. The firm formed in 1979 and its products reduce risk trauma cost procedure time and aftercare needs. Boston Scientific acquired BTG plc in Q3 2019 a developer of products for cancer and vascular disease procedures.
General information
Firm type
Venture Capital
Year founded
1979
Location
Region
North America
Country
United States
City
Marlborough
Corporate office
300 Boston Scientific Way, Marlborough, MA 01752-1234, United States
Principals
Michael F. Mahoney
Chairman and CEO
Kristopher Carver
Senior Manager of Venture Capital
Sector focus
Frequently asked questions
Who runs investment decisions at Boston Scientific Ventures?
Michael F. Mahoney serves as Chairman and CEO of the parent corporation and oversees strategic venture direction. Kristopher Carver acts as Senior Manager of Venture Capital.
Does Boston Scientific Ventures participate in fund commitments or only direct deals?
The unit holds direct ownership positions in portfolio companies including SetPoint Medical and 4C Medical through Boston Scientific Ventures.
What investment stages does Boston Scientific Ventures typically target?
The unit focuses on early-stage seed and startup investments as well as expansion and growth rounds in therapeutic devices.
Where does the underlying wealth come from?
Boston Scientific Corporation generates revenue from worldwide sales of medical devices and technologies. The company was founded in 1979 by Pete Nicholas and John Abele.
How is Boston Scientific Ventures related to the parent corporation?
Boston Scientific Ventures functions as the internal corporate venture program of Boston Scientific Corporation, which maintains public listing under ticker BSX.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: